Inspire Medical Systems Hits New 52-Week Low at $50.00

Inspire Medical Systems, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 50.00 as of March 26, 2026. This significant decline marks a stark contrast to the stock's previous high of USD 164.02, reflecting a year-to-date performance drop of 68.66%. The company's market capitalization stands at USD 1,683 million, indicating its position within the small-cap category. Inspire Medical Systems has a price-to-earnings (P/E) ratio of 11.00, which is noteworthy in comparison to broader market metrics. The company currently does not offer a dividend, and its debt-to-equity ratio is reported at -0.39, suggesting a unique financial structure. Additionally, Inspire Medical Systems boasts a return on equity of 19.13% and a price-to-book ratio of 2.15, highlighting its asset valuation relative to its market price. As the stock navigates these recent lows, it reflects broader trends within the industry and the company's performance metrics.